Hospital Univ. Central de Asturias; Servicio de Oncologia

Oviedo, Principality of Asturias 33011

0 studies enrolling now · 3 studies all time

What they study most

Gastric Cancer, Multiple Myeloma, Neoplasms, Renal Cell Carcinoma

Studies at this site

• A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy — Stopped early
• A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers — Completed
• A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer — Stopped early